Stock ITCI INTRA-CELLULAR THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

Delayed Nasdaq
Other stock markets
 03:58:46 2024-04-29 pm EDT 		5-day change 1st Jan Change
72.28 USD -1.34% Intraday chart for Intra-Cellular Therapies, Inc. -3.09% +0.87%
Apr. 23 Canaccord Genuity Raises Intra-Cellular Therapies' Price Target to $107 From $100, Maintains Buy Rating MT
Apr. 22 Needham & Co Adjusts Intra-Cellular Therapies Price Target to $90 From $82, Maintains Buy Rating MT

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ITCI Stock
  4. News Intra-Cellular Therapies, Inc.
  5. MarketScreener Strategies